MEREO BIOPHARMA GROUP PLC (MREO) Deferred Tax Assets, Gross

MEREO BIOPHARMA GROUP PLC Deferred Tax Assets, Gross

MEREO BIOPHARMA GROUP PLC (MREO) had Deferred Tax Assets, Gross of $226.76 million as of 2025-12-31, per its 10-K filed 2026-03-19.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsGross · last filed 2026-03-19

• 2025-12-31: Deferred Tax Assets, Gross $226.76M.
• 2024-12-31: Deferred Tax Assets, Gross $215.02M.
• 2023-12-31: Deferred Tax Assets, Gross $206.34M.
• 2022-12-31: Deferred Tax Assets, Gross $197.24M.